rs370337339
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_052874.5(STX1B):c.105+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,602,130 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 2 hom. )
Consequence
STX1B
NM_052874.5 intron
NM_052874.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.920
Genes affected
STX1B (HGNC:18539): (syntaxin 1B) The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 16-31001519-G-A is Benign according to our data. Variant chr16-31001519-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 475338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 26 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STX1B | NM_052874.5 | c.105+10C>T | intron_variant | ENST00000215095.11 | NP_443106.1 | |||
STX1B | XM_017022893.2 | c.87+10C>T | intron_variant | XP_016878382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STX1B | ENST00000215095.11 | c.105+10C>T | intron_variant | 1 | NM_052874.5 | ENSP00000215095 | P1 | |||
STX1B | ENST00000565419.2 | c.105+10C>T | intron_variant | 2 | ENSP00000455899 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152058Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
26
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000995 AC: 24AN: 241320Hom.: 1 AF XY: 0.0000914 AC XY: 12AN XY: 131230
GnomAD3 exomes
AF:
AC:
24
AN:
241320
Hom.:
AF XY:
AC XY:
12
AN XY:
131230
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000223 AC: 323AN: 1450072Hom.: 2 Cov.: 31 AF XY: 0.000204 AC XY: 147AN XY: 721594
GnomAD4 exome
AF:
AC:
323
AN:
1450072
Hom.:
Cov.:
31
AF XY:
AC XY:
147
AN XY:
721594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000171 AC: 26AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74268
GnomAD4 genome
AF:
AC:
26
AN:
152058
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74268
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 30, 2019 | - - |
Generalized epilepsy with febrile seizures plus, type 9 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at